HIK — Hikma Pharmaceuticals Share News
0.000.00%
- £4.72bn
- £5.54bn
- $3.16bn
- 90
- 41
- 96
- 92
REG - Hikma Pharmaceutical - Hikma acquires Custopharm
AnnouncementREG - Stock Exch Notice - Admission to Trading - 24/09/2021
AnnouncementREG - Hikma Pharmaceutical - Additional Listing
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementRCS - Hikma Pharmaceutical - Bio-Thera and Hikma announce exclusive agreement
AnnouncementREG - Hikma Pharmaceutical - Half-year Report
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Notice of Results
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementRCS - Hikma Pharmaceutical - Hikma announces US FDA approval of KLOXXADO
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Result of AGM
AnnouncementREG - Hikma Pharmaceutical - Hikma resumes launch of generic Advair Diskus®
AnnouncementREG - Hikma Pharmaceutical - Block listing Interim Review
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
Announcement